Re: Incyte IDO combo
If PV-10 P3 trial sites are participating in these combo trials isnt it hard for us to recruit Stage IIIB,C and IVa patients ? If patient eligible for combo trial and PV-10 P3 trial, I dont think there will be any second thought which one patients will choose. Only those ineligible for combo trials and failed checkpoint inhibitors who didn't progress to metastatic melanoma (Stage IV B/c) will opt for PV-10 P3 trial. I think with each addition of combo trial we will have hard time recruiting patients into PV-10 P3 trial.